News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,493 Results
Type
Article (41716)
Company Profile (326)
Press Release (660451)
Section
Business (210078)
Career Advice (2069)
Deals (36565)
Drug Delivery (95)
Drug Development (82760)
Employer Resources (171)
FDA (16474)
Job Trends (15347)
News (355293)
Policy (33810)
Tag
Academia (2574)
Alliances (51032)
Alzheimer's disease (1230)
Approvals (16391)
Artificial intelligence (124)
Bankruptcy (362)
Best Places to Work (11592)
Biotechnology (210)
Breast cancer (103)
Cancer (909)
Career advice (1733)
Cell therapy (196)
Clinical research (65418)
Collaboration (324)
Compensation (159)
COVID-19 (2591)
Cystic fibrosis (80)
Data (837)
Diabetes (130)
Diagnostics (6175)
Drug pricing (85)
Earnings (85775)
Employer resources (149)
Events (111598)
Executive appointments (246)
FDA (16912)
Funding (290)
Gene therapy (156)
GLP-1 (588)
Government (4435)
Healthcare (18830)
Infectious disease (2664)
Inflammatory bowel disease (105)
Interviews (319)
IPO (16540)
Job creations (4049)
Job search strategy (1485)
Layoffs (427)
Legal (8311)
Lung cancer (156)
Manufacturing (157)
Medical device (13225)
Medtech (13230)
Mergers & acquisitions (20024)
Metabolic disorders (365)
Neuroscience (1477)
NextGen Class of 2024 (6618)
Non-profit (4510)
Northern California (1185)
Obesity (219)
Opinion (199)
Patents (97)
People (58062)
Pharmaceutical (92)
Phase I (20205)
Phase II (28776)
Phase III (21622)
Pipeline (204)
Postmarket research (2643)
Preclinical (8607)
Radiopharmaceuticals (239)
Rare diseases (188)
Real estate (6238)
Regulatory (22268)
Research institute (2356)
Resumes & cover letters (358)
Southern California (1069)
Startups (3710)
United States (11585)
Vaccines (552)
Weight loss (171)
Date
Last 7 days (783)
Last 30 days (2688)
Last 365 days (36119)
2024 (30593)
2023 (40628)
2022 (51797)
2021 (56331)
2020 (54795)
2019 (47400)
2018 (35771)
2017 (33138)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (193)
Asia (39868)
Australia (6370)
California (2689)
Canada (1169)
China (212)
Colorado (117)
Connecticut (120)
Europe (84824)
Florida (386)
Georgia (98)
Illinois (313)
Indiana (183)
Kansas (95)
Maryland (513)
Massachusetts (2204)
Michigan (143)
Minnesota (247)
New Jersey (819)
New York (828)
North Carolina (674)
Northern California (1185)
Ohio (123)
Pennsylvania (741)
South America (1157)
Southern California (1069)
Texas (381)
Washington State (322)
702,493 Results for "adarx pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
ADARx Pharmaceuticals, Inc. today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).
April 2, 2024
·
3 min read
Biotech Beach
ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference
ADARx Pharmaceuticals, Inc. today announced that Zhen Li, PhD, Co-Founder, President and CEO, will host one-on-one investor meetings at the 44th Annual Cowen Healthcare Conference on Monday, March 4, 2024 in Boston, Massachusetts.
February 21, 2024
·
1 min read
Press Releases
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
July 30, 2024
·
3 min read
Biotech Beach
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference.
January 3, 2024
·
1 min read
Biotech Beach
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing.
August 9, 2023
·
3 min read
Biotech Beach
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the close of a $46 million Series B-1 financing to advance its drug development pipeline as the Company’s first product enters the clinic.
January 20, 2023
·
2 min read
Drug Development
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the dosing of the first cohort in a Phase 1 clinical study of ADX-324 for the treatment of hereditary angioedema (HAE).
January 20, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Robert MacLeod, Ph.D. as Chief Scientific Officer.
January 9, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO
ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Christopher Prentiss as Chief Financial Officer.
September 28, 2022
·
2 min read
Business
ADARx Pharmaceuticals Further Expands Leadership Team, Appointing Feriandas Greblikas, M.D. as VP of Clinical Development
ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, today announced the further expansion of their leadership team and clinical development capabilities through the appointment of Feriandas Greblikas, M.D. as Vice President of Clinical Development.
October 18, 2022
·
2 min read
1 of 70,250
Next
